Insensitive irritable bowel syndrome

December 18, 2015, Technical University Munich
The irritable bowel syndrome is associated with typical symptoms such as abdominal pain or cramping. It had long been speculated that irritable bowel syndrome is a psychosomatic disorder. Credit: iStock/SomkiatFakmee

For the first time, biopsies of patients with irritable bowel syndrome have shown that the nerves in their gut wall respond poorly to a cocktail of inflammatory substances. This refutes the previous theory that patients with irritable bowel syndrome have an overly sensitive gut. The new study by scientists of the Technical University of Munich (TUM) was carried out in collaboration with several German hospitals.

Irritable bowel syndrome affects around ten to 15 percent of people in industrialized countries. The disease is associated with typical symptoms such as abdominal pain, bloating and irregular bowel movements. It had long been speculated that irritable bowel syndrome is a psychosomatic disorder triggered by stress. To date, there is no specific treatment for the disease itself, only for the accompanying symptoms. In the meantime it is recognized that irritable bowel syndrome is in fact an organic disorder; however, the manifold causes, cannot be detected with today's measurement methods in routine practice. A new study, published in Frontiers in Neuroscience, has now shown, for the first time, that measurable changes occur in the nerves in the gut wall of patients with irritable bowel syndrome.

Nerve sensitization can be ruled out

"One possible cause of symptoms in some irritable bowel syndrome patients is the increased release of neurotransmitters," says Professor Michael Schemann of the TUM Department of Human Biology. "These substances play a role in inflammatory processes, among other things." Based on their own earlier studies, the TUM researchers postulated that the nerves in the gut wall of irritable bowel syndrome patients are highly sensitive. They therefore examined the reaction of biopsy samples from irritable bowel syndrome patients and to and nicotine. Both are well-established methods for testing the responsiveness of enteric nerves: Electrical stimulation results in synaptic transmission, while nicotine directly activates enteric nerves. Surprisingly, the nerves of both groups reacted similarly, so that general sensitization can be ruled out.

Perplexing results: irritable bowels have reduced sensitivity

The researchers then administered a cocktail of inflammatory substances containing histamine, proteases, serotonin and TNF-alpha in order to simulate the environment in the gut wall of patients with irritable bowel syndrome and measured the response. The results were perplexing: "What we found was exactly the opposite of what we initially surmised. The nerves of irritable bowel syndrome patients reacted much less strongly to the cocktails we administered than the of healthy volunteers," says Professor Schemann. "The gut wall of these patients is evidently desensitized as a result of earlier excessive activation. This could be a protective measure to prevent overstimulation."

To verify this conclusion, enteric nerves were exposed to irritation for several hours. The result: "When the nerves are irritated continuously, they down-regulate the reaction," says Schemann, who has been studying for years. He emphasizes that these sophisticated experimental investigations are a long way from being used for routine diagnosis. "It remains unclear how the observed desensitization of the nerves to specific neurotransmitters causes the actual symptoms and whether this phenomenon will lead to new therapeutic options."

Although experiments show a decreased response to an inflammatory cocktail, they do not rule out the possibility of sensitization to other substances.

Explore further: Definitive tests for irritable bowel syndrome developed

More information: Daniela Ostertag et al. Reduced Responses of Submucous Neurons from Irritable Bowel Syndrome Patients to a Cocktail Containing Histamine, Serotonin, TNFα, and Tryptase (IBS-Cocktail), Frontiers in Neuroscience (2015). DOI: 10.3389/fnins.2015.00465

Related Stories

Definitive tests for irritable bowel syndrome developed

May 14, 2015
Millions of people afflicted by irritable bowel syndrome can now be diagnosed quickly and accurately with two simple blood tests developed by a Cedars-Sinai gastroenterologist.

Scientists uncover changes in proteins that regulate 'gut leakiness' and identify a link with common digestive diseases

May 27, 2013
Scientists at Trinity College Dublin have made an important advance in understanding the biological factors that keep the lining of the gut wall intact. Associate Professor, Maria O'Sullivan at Trinity's School of Medicine ...

Bowel illnesses sometimes coincide in kids

April 21, 2014
(HealthDay)—Children suffering from irritable bowel syndrome are four times more likely than other kids to have a condition called celiac disease—an allergy to gluten—Italian researchers report.

Low FODMAP diet cuts irritable bowel syndrome symptoms

November 14, 2015
(HealthDay)—A diet with reduced content of fermentable short-chain carbohydrates (fermentable oligo-, di-, monosaccharides, and polyols [FODMAPs]) reduces symptoms of irritable bowel syndrome (IBS), with reductions similar ...

Biomarkers can reveal irritable bowel syndrome

May 7, 2012
Irritable bowel syndrome (IBS) is hard to diagnose as well as treat, but researchers at the Sahlgrenska Academy, at the University of Gothenburg, Sweden, have discovered a way of confirming the disorder using stool samples.

Recommended for you

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

Flu shot only 36 percent effective, making bad year worse (Update)

February 15, 2018
The flu vaccine is doing a poor job protecting older Americans and others against the bug that's causing most illnesses.

IFN-mediated immunity to influenza A virus infection influenced by RIPK3 protein

February 15, 2018
Each year, influenza kills half a million people globally with the elderly and very young most often the victims. In fact, the Centers for Disease Control and Prevention reported 37 children have died in the United States ...

A new class of drug to treat herpes simplex virus-1 infection

February 14, 2018
For patients with the herpes simplex-1 virus (HSV-1), there are just a handful of drugs available to treat the painful condition that can affect the eyes, mouth and genitals.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.